Home/Owkin/Thomas Clozel
TC

Thomas Clozel

Co-founder and Chief Executive Officer

Owkin

Owkin Pipeline

DrugIndicationPhase
AI Drug Discovery PipelineOncology & other diseasesDiscovery
OKN4395Oncology (Immunotherapy)Pre-clinical
MSIntuit® CRCColorectal Cancer (MSI screening)Approved
RlapsRisk® BCEarly Breast CancerApproved
Glioblastoma MoonshotGlioblastomaResearch
K ProDrug Discovery & Development PlatformCommercial